Roche's Win Over $12M Accutane Judgments Stands In NJ

Law360, New York (January 17, 2013, 3:24 PM EST) -- In a win for Hoffmann-La Roche Inc., the New Jersey Supreme Court on Wednesday declined to review a decision reversing judgments totaling $11.8 million for three plaintiffs who claimed they developed inflammatory bowel disease after taking acne drug Accutane.

The high court denied the petition for certification of one-time Accutane users who had sued Roche under Florida law.

The state's Appellate Division ruled in August that under a Florida appeals court's reading of the learned intermediary doctrine, a company cannot be held liable for a plaintiff's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.